title: Adalimumab for cutaneous metastatic Crohn's disease.
authors.forename: Didia Bismara
authors.initials: DB
authors.lastname: Cury
authors.forename: Alan C
authors.initials: AC
authors.lastname: Moss
authors.forename: Geraldo
authors.initials: G
authors.lastname: Elias
authors.forename: Alexandre
authors.initials: A
authors.lastname: Nakao
mesh_terms: D000068879:Adalimumab; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011379:Prognosis; D012074:Remission Induction; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab